Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
39.80
+0.46 (1.17%)
Nov 21, 2024, 4:00 PM EST - Market closed
Xenon Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3,034 | 3,503 | 2,466 | 1,643 | 554 | 353 | |
| Market Cap Growth | 36.13% | 42.03% | 50.06% | 196.62% | 57.13% | 108.45% | |
| Enterprise Value | 2,206 | 2,875 | 1,721 | 1,397 | 364 | 274 | |
| Last Close Price | 39.34 | 46.06 | 39.43 | 31.24 | 15.38 | 13.11 | |
| PS Ratio | - | - | 261.41 | 89.14 | 17.22 | 51.63 | |
| PB Ratio | 3.74 | 3.77 | 3.42 | 2.99 | 3.23 | 3.83 | |
| P/TBV Ratio | 3.74 | 3.77 | 3.42 | 2.99 | 3.23 | 3.83 | |
| PEG Ratio | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | 2.51 | |
| EV/Sales Ratio | - | - | 182.44 | 75.77 | 11.31 | 40.18 | |
| Debt / Equity Ratio | - | 0.01 | 0.01 | 0.02 | 0.02 | 0.18 | |
| Asset Turnover | - | - | 0.01 | 0.05 | 0.19 | 0.05 | |
| Quick Ratio | 22.02 | 23.43 | 26.12 | 38.72 | 12.10 | 3.28 | |
| Current Ratio | 22.21 | 23.65 | 26.44 | 39.03 | 12.30 | 3.34 | |
| Return on Equity (ROE) | -29.75% | -22.12% | -19.72% | -21.87% | -21.90% | -42.60% | |
| Return on Assets (ROA) | -21.19% | -15.57% | -12.17% | -12.97% | -11.61% | -19.81% | |
| Return on Capital (ROIC) | -22.10% | -16.01% | -12.51% | -13.47% | -13.82% | -23.61% | |
| Earnings Yield | -6.88% | -5.21% | -5.08% | -4.80% | -5.20% | -11.80% | |
| FCF Yield | -4.31% | -4.11% | -4.35% | -9.16% | -1.69% | |
| Buyback Yield / Dilution | -16.41% | -10.48% | -38.77% | -21.09% | -23.57% | -8.92% | |
| Total Shareholder Return | -16.41% | -10.48% | -38.77% | -21.09% | -23.57% | -8.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.